Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03906331
Title Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Loxo Oncology, Inc.
Indications

Advanced Solid Tumor

Therapies

Selpercatinib

Age Groups: child | senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST